Suchergebnisse - "Tang, Hailin"

PubPharm (405)

71

Combined preparation for reversing drug resistance of breast cancer and application of marker

enthalten in: Europäisches Patentamt | 2022

von XIE XIAOMING | TANG HAILIN | ZOU YUTIAN | +10

72

Combined preparation for reversing drug resistance of breast cancer and application of marker

enthalten in: Europäisches Patentamt | 2022

von XIE XIAOMING | TANG HAILIN | ZOU YUTIAN | +10

73

Application of etravirine in preparation of medicine for resisting tick-borne encephalitis virus, west nile virus, yellow fever virus and chikungunya virus infection

enthalten in: Europäisches Patentamt | 2022

von ZHENG XU | ZHAO PING | TANG HAILIN | +4

74

Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo

enthalten in: Science China. Life sciences | 2022

von Peng, H. | Ding, C. | Jiang, L. | +12

75

Two-Dimensional MXene-Originated In Situ Nanosonosensitizer Generation for Augmented and Synergistic Sonodynamic Tumor Nanotherapy

enthalten in: ACS nano | 2022

von Zhang, M. | Yang, D. | Dong, C. | +7

76

High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses

enthalten in: Viruses | 2022

von Ding, C. | Tang, W. | Xia, B. | +11

77

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

enthalten in: Nature communications | 2022

von Zou, Y. | Zheng, S. | Xie, X. | +14

78

Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways

enthalten in: Molecular medicine reports | 2022

von Yuan, F. | Gao, Q. | Tang, H. | +2

79

Correction to : Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

enthalten in: Journal of experimental & clinical cancer research : CR | 2022

von Wang, N. | Wang, Q. | Tang, H. | +6

ErratumFor: J Exp Clin Cancer Res. 2017 Dec 02;36(1):172. - PMID 29197410

80

Correction to: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

enthalten in: Journal of experimental & clinical cancer research | 2022

von Wang, N. | Wang, Q. | Tang, H. | +6